Jerome D. Jabbour
Chief Executive Officer
Matinas BioPharma is a clinical-stage biopharmaceutical company focused on development of its lead product candidate, MAT9001, for the treatment of cardiovascular and metabolic conditions.
NYSE AMER: MTNB
President and Chief Executive Officer, Board Director
Omega Therapeutics™ is a genomic medicine company focused on selectively directing the human genome to treat and cure disease by precisely controlling genomic expression without changing nucleic acid sequences.
Chief Executive Officer and President
Celavie Biosciences is a privately-held company whose mission is to improve lives and restore hope by advancing regenerative stem cell therapies for the treatment of Parkinson’s disease and other disorders of the central nervous system (CNS).
Mark Tepper, Ph.D.
President and Chief Executive Officer
EuMentis Therapeutics Inc. is a privately held biopharmaceutical company focused on developing novel therapies to treat high value neurodevelopmental and neurodegenerative diseases.
DeMelle OncoPharma LLC is focused on developing pharmacological treatments for high-unmet need cancers, initially for pancreatic cancer.
© 2020 Virtual Investor Summit All rights reserved.
Dr. Klaus Paulini
Executive Director; President and Chief Executive Officer;
Managing Director, Aeterna Zentaris GmbH
Aeterna Zentaris is a biotech company commercializing and developing therapeutic and diagnostic tests, particularly for growth hormone deficiency (GHD). Our lead product, macimorelin, is approved to diagnose adult GHD and being developed to diagnose pediatric GHD.
Chief Operating Officer, Executive Director
SIRION Biotech was founded in 2005 to lead the next generation of comprehensive viral vector technology platforms based on lenti-, adeno-, and adeno-associated viruses which expedites gene therapy research and advances drug development.